| Similar Articles |
|---|
 |
Fast Company
November 1999
John Ellis |
Digital Matters - Issue 29 In My Humble Opinion: Genomics is the most important economic, political, and ethical issue facing mankind.   |
Fast Company
September 2000
John Ellis |
The Secret of Life The mapping of the human genome, says Craig Venter, will change science, research, medicine, politics, health insurance, and the way biology looks at the last 3 billion years of evolution. And that's just the beginning. |
Fast Company
September 2000
John Ellis |
Digital Matters "We are nearing the end of tedious, dull and small politics." |
The Motley Fool
February 29, 2008
Jack Uldrich |
Agriculture Sector Looks Good in Genes Innovations in genomics and supercomputing will fuel the agriculture sector's future growth. |
The Motley Fool
February 27, 2009
Brian Orelli |
Hooray for Stalemates! Government deadlock will likely bring more genetically engineered seeds to the EU, and good news for Syngenta, DuPont, and Dow Chemical. |
The Motley Fool
March 31, 2004
W.D. Crotty |
Monsanto in the Balance Genetically modified crops are a boon for the company. |
Bio-IT World
November 12, 2002
Davies et al. |
John Craig Venter Unvarnished The former Celera CEO talks about that company's politics, the future of sequencing technology, and his own genome. |
The Motley Fool
June 19, 2007
Jack Uldrich |
BP's New Design A deal with a private biotech company offers great promise. The deal helps move the energy company beyond petroleum. |
Registered Rep.
April 1, 2006
Bob Hirschfeld |
Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly? |
The Motley Fool
April 5, 2006
Stephen D. Simpson |
This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note. |
The Motley Fool
March 20, 2007
Tim Hanson & Brian Richards |
Stocks to Bet the House On Margin is a dangerous game. The easiest way to crush the market over the next few decades is to be the patient long-term owner of great companies. |
The Motley Fool
December 6, 2011
Neha Chamaria |
Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious? |
Chemistry World
November 10, 2014
Rebecca Trager |
US states reject GM labeling laws Voters in Oregon and Colorado have rejected ballot measures that would have required foods containing genetically modified organisms to be labeled as such in those states. |
Reason
Aug/Sep 2000
Ronald Bailey |
Strands of Life Book Review: Genome: The Autobiography of a Species in 23 Chapters, by Matt Ridley |
The Motley Fool
June 26, 2007
Rich Duprey |
Foolish Forecast: Monsanto's Monstrous Growth Agricultural products company Monsanto will report third-quarter 2007 financial results on Thursday. Will investors on the sidelines be green with envy? |
The Motley Fool
April 15, 2009
Brian Orelli |
No Bumper Crop, but Bans Aplenty for Monsanto Germany's move to ban planting of Monsanto's genetically modified corn seeds won't be a major hit to sales, but it's the thought that counts. |
The Motley Fool
March 23, 2007
Alyce Lomax |
Is Monsanto Going to Seed? Several recent news headlines referring to its genetically modified products should give investors some reason to contemplate the risks that face this biotech giant. |
The Motley Fool
August 26, 2009
Rick Aristotle Munarriz |
Throw This Stock Away It may be time to get rid of Gannett stock, and think about replacing it with one of these three: Google... Amazon.com... 51job... |
Salon.com
October 19, 2001
Katharine Mieszkowski |
The genetically engineered pause that refreshes Corn chips and sodas are just two examples of today's "Frankenfoods," says the author of "Dinner at the New Gene Cafe"... |
